<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore results regarding NORT of ex vivo %DPPH free radicals scavenging activity in cortex and hippocampus of different animals groups are presented in 
 <xref ref-type="fig" rid="brainsci-11-00259-f008">Figure 8</xref>C,D. %DPPH inhibition activity in the cortex and hippocampus of scopolamine-treated groups were significantly (**: 
 <italic>p</italic> &lt; 0.01) lower (14.6 + 0.2 and 19.4 + 0.5) as compared to normal saline group (44.6 + 0.3 and 58.0 + 0.4.). Fa.EtAc + Scop (50 mg/kg, p.o.), Fa.EtAc + Scop (100 mg/kg, p.o.), and Fa.EtAc + Scop (200 mg/kg, p.o.) and standard donepezil-treated groups showed significantly higher %anti-radicals activities of 24.6 + 0.1 
 <sup>#</sup>, 31.6 + 0.5 
 <sup>##</sup>, 38.2 + 0.4 
 <sup>##</sup>, and 49.4 + 0.1 
 <sup>###</sup> in cortex and 33.6 + 0.5 
 <sup>#</sup>, 51.4 + 0.5 
 <sup>##</sup>, 56.8 + 0.2 
 <sup>##</sup>, and 62.0 + 0.3 
 <sup>##</sup> in the hippocampus, respectively. 
</p>
